NeueHealth 2024年第四季度GAAP每股收益$(7.41)未達預期$(2.48),銷售額為$2.32638億未達預期$2.51930億

財報速遞
03-20
NeueHealth (NYSE:NEUE)報告的季度每股虧損爲$(7.41),比分析師的共識估計$(2.48)低198.79%。這比去年同期每股收益$19.54減少了137.92%。公司報告的季度銷售額爲$2.32638億,比分析師的共識估計$2.51930億低7.66%。這比去年同期銷售額$2.92871億減少了20.57%。

以上內容來自Benzinga Earnings專欄,原文如下:

NeueHealth (NYSE:NEUE) reported quarterly losses of $(7.41) per share which missed the analyst consensus estimate of $(2.48) by 198.79 percent. This is a 137.92 percent decrease over earnings of $19.54 per share from the same period last year. The company reported quarterly sales of $232.638 million which missed the analyst consensus estimate of $251.930 million by 7.66 percent. This is a 20.57 percent decrease over sales of $292.871 million the same period last year.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10